Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings

Risk of venous thromboembolism during the use of oral estrogen-progestogen hormone therapies in light of most recent research findings

Two important studies evaluating the safety profile of oral estrogen-progestogen hormonal therapies conducted in standard clinical practice with respect to the venous system were recently published. A large prospective controlled cohort study (PRO-E2) based on the non-inferiority design has shown...

Full description

Bibliographic Details
Main Authors: Małgorzata Bińkowska, Artur Jakimiuk, Tomasz Paszkowski, Leszek Pawelczyk, Violetta Skrzypulec-Plinta
Format: Article
Language:English
Published: Termedia Publishing House 2022-10-01
Series:Menopause Review
Subjects:
venous thromboembolism
combined oral hormonal contraception
menopausal hormone therapy
Online Access:https://www.termedia.pl/Risk-of-venous-thromboembolism-during-the-use-of-oral-estrogen-progestogen-hormone-therapies-in-light-of-most-recent-research-findings,4,47897,1,1.html

Internet

https://www.termedia.pl/Risk-of-venous-thromboembolism-during-the-use-of-oral-estrogen-progestogen-hormone-therapies-in-light-of-most-recent-research-findings,4,47897,1,1.html

Similar Items